This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (106)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Llewellyn I. Kitchin, MD; Donald O. Castell, MD

Arch Intern Med. 1991;151(3):448-454.

Abstract
Major recent advances in the diagnosis and understanding of gastroesophageal reflux disease have afforded the practicing clinician a number of therapeutic options to treat the increasingly recognized affected patient population. With highly effective acid-suppressive therapies available, simple life-style modifications, such as selective food and medicine avoidance, weight loss, smoking cessation, elevation of the head of the bed, and the judicious use of antacids and alginate, have been relegated to a minor, if any, role in the management of these patients. The validity of these recommendations, however, remains consistent with our current understanding of the pathogenesis of gastroesophageal reflux disease. Although few well-designed placebo-controlled trials have been conducted, a review of the medical literature indicates an appreciable efficacy of these interventions, which are founded on well-studied physiologic determinants of gastroesophageal reflux. Most patients with gastroesophageal reflux disease can be managed by reassurance and simple life-style adjustments alone. The therapy for those with chronic or relapsing disease should always include the adjunctive reinforcement of these simple, efficacious, and cost-effective measures.

(Arch Intern Med. 1991;151:448-454)

Author Affiliations
From the Division of Gastroenterology and Hepatology, Jefferson Medical College, Philadelphia, Pa.

Footnotes
Accepted for publication September 25, 1990.

Reprint requests to the Division of Gastroenterology and Hepatology, Jefferson Medical College, 1025 Walnut St, Philadelphia, PA 19107 (Dr Castell).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Are lifestyle measures effective in patients with gastroesophageal reflux disease?: an evidence-based approach.
Kaltenbach et al.
Arch Intern Med 2006;166:965-971.
ABSTRACT | FULL TEXT  

Chronic Cough Due to Gastroesophageal Reflux Disease: ACCP Evidence-Based Clinical Practice Guidelines
Irwin
Chest 2006;129:80S-94S.
ABSTRACT | FULL TEXT  

Low-Fat, High Fruit and Vegetable Diets and Weight Loss Do Not Affect Biomarkers of Cellular Proliferation in Barrett Esophagus
Kristal et al.
Cancer Epidemiol. Biomarkers Prev. 2005;14:2377-2383.
ABSTRACT | FULL TEXT  

Meta-Analysis: Obesity and the Risk for Gastroesophageal Reflux Disease and Its Complications
Hampel et al.
ANN INTERN MED 2005;143:199-211.
ABSTRACT | FULL TEXT  

The Persistently Troublesome Cough
Irwin and Madison
Am. J. Respir. Crit. Care Med. 2002;165:1469-1474.
FULL TEXT  

An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori
van Zanten et al.
CMAJ 2000;162:s3-23.
ABSTRACT | FULL TEXT  

Fortnightly review: Treatment of gastro-oesophageal reflux disease in adults
Galmiche et al.
BMJ 1998;316:1720-1723.
FULL TEXT  

Gastro-oesophageal reflux: does it matter what you eat?
GALMICHE
Gut 1998;42:318-319.
FULL TEXT  

Guidelines for the Diagnosis and Treatment of Gastroesophageal Reflux Disease
DeVault et al.
Arch Intern Med 1995;155:2165-2173.
ABSTRACT  

Categories of Patients With Gastroesophageal Reflux
Graham
Arch Intern Med 1991;151:2476-2476.
ABSTRACT